Jun 15, 2024, 09:46
Amer Zeidan: Amazing work by our Yale Hematology Oncology Fellows at EHA2024
Amer Zeidan shared a post on X:
“Amazing work by our Yale Hematology Oncology Fellows presenting 6 posters at European Hematology Association
EHA2024 meeting in Madrid Dr. Jessica Stemple, Dr. Theodore Getz, Dr. Tariq Kewan & incoming faculty Dr. Jan Bewersdorf Yale Cancer Center, Yale Hematology, Yale School of Medicine, Yale University using International Consortium for MDS (icMDS) database.”
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46